Ainos (NASDAQ:AIMD) Director Chun-Jung Tsai Sells 27,718 Shares of Stock

Ainos, Inc. (NASDAQ:AIMD) Director Chun-Jung Tsai sold 27,718 shares of the stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $1.87, for a total transaction of $51,832.66. Following the sale, the director directly owned 658,199 shares of the company’s stock, valued at approximately $1,230,832.13. This represents a 4.04% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Chun-Jung Tsai also recently made the following trade(s):

• On Friday, May 22nd, Chun-Jung Tsai sold 1,082 shares of Ainos stock. The shares were sold at an average price of $1.55, for a total transaction of $1,677.10.

Ainos Stock Down 19.0%

AIMD stock opened at $2.56 on Thursday. Ainos, Inc. has a 12 month low of $1.26 and a 12 month high of $4.50. The firm has a 50 day simple moving average of $1.67 and a 200 day simple moving average of $1.83. The company has a debt-to-equity ratio of 1.58, a current ratio of 0.55 and a quick ratio of 0.50. The firm has a market cap of $21.81 million, a PE ratio of -0.89 and a beta of 2.29.

Ainos (NASDAQ:AIMD) last released its quarterly earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter. Ainos had a negative net margin of 11,912.10% and a negative return on equity of 160.55%.

Analysts Set New Price Targets

Separately, Weiss Ratings upgraded shares of Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Ainos currently has a consensus rating of “Sell”.

Institutional Trading of Ainos

Several large investors have recently added to or reduced their stakes in AIMD. Mariner LLC bought a new stake in Ainos in the fourth quarter worth approximately $37,000. Two Sigma Investments LP bought a new stake in shares of Ainos during the 3rd quarter worth $80,000. DRW Securities LLC boosted its holdings in shares of Ainos by 272.6% during the 4th quarter. DRW Securities LLC now owns 66,211 shares of the company’s stock worth $109,000 after buying an additional 48,439 shares during the period. Finally, Renaissance Technologies LLC boosted its holdings in shares of Ainos by 13.1% during the 4th quarter. Renaissance Technologies LLC now owns 66,300 shares of the company’s stock worth $109,000 after buying an additional 7,700 shares during the period.

About Ainos

Ainos, Inc (NASDAQ: AIMD) is a clinical‐stage biopharmaceutical company dedicated to developing inhalation therapies for patients with chronic pulmonary disorders. The company’s proprietary platform centers on a dry powder inhalation technology designed to deliver therapeutic agents directly to the lungs, potentially improving drug distribution and reducing systemic side effects compared to traditional oral or intravenous formulations.

The lead product candidate, AI‐401, is an inhaled formulation of ibuprofen in a dry powder format.